Tag: MVMD.C
-
Mountain Valley MD Holdings (MVMD.C) new patent and preclinicals put cancer in their sights
Mountain Valley MD Holdings (MVMD.C) filed a cancer patent and is moving forward with preclinical trials with third party cancer research organizations (CROs) in triple-negative breast cancer, metastatic melanoma and lung carcinoma, according to a press release. The patent is called Novel Injectable, Infusable, Instillable Ivermectin Adjuvant for Cancer Therapies, and involves solubilized ivermectin (also…
-
Parry Special: Short report on Mountain Valley MD Holdings (MVMD.C) earns nothing but rage
When a ‘devastating’ expose on a company opens with the line ‘We are short this company’, I have to say, I find it hard to read much further. To open the discussion admitting you’ll make more money if the company you’re writing about gets obliterated, and then proceed to map out your obliteration strategy, well…